Experiment: 5LDL

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D CBCA(CO)NH	1 mM [U-13C; U-15N] myristoylated retroviral matrix protein, 100 mM phosphate, 300 mM sodium choride, 5 mM DTT	90% H2O/10% D2O	600 mM	6	1 atm	298	Bruker AVANCE III 600
2	2D 1H-15N HSQC IPAP	400 mM [U-15N] myristoylated retroviral matrix protein, 50 mM phosphate, 150 mM sodium choride, 5 mM DTT, 10 mg/mL Pf1 phage	90% H2O/10% D2O	600 mM	6	1 atm	298	Bruker AVANCE III 600
3	3D HNCACB	1 mM [U-13C; U-15N] myristoylated retroviral matrix protein, 100 mM phosphate, 300 mM sodium choride, 5 mM DTT	90% H2O/10% D2O	600 mM	6	1 atm	298	Bruker AVANCE III 600
4	3D HCCH-TOCSY	1 mM [U-13C; U-15N] myristoylated retroviral matrix protein, 100 mM phosphate, 300 mM sodium choride, 5 mM DTT	90% H2O/10% D2O	600 mM	6	1 atm	298	Bruker AVANCE III 600
5	3D 1H-13C NOESY	1 mM [U-13C; U-15N] myristoylated retroviral matrix protein, 100 mM phosphate, 300 mM sodium choride, 5 mM DTT	90% H2O/10% D2O	600 mM	6	1 atm	298	Bruker AVANCE III 600
6	3D 1H-15N NOESY	1 mM [U-13C; U-15N] myristoylated retroviral matrix protein, 100 mM phosphate, 300 mM sodium choride, 5 mM DTT	90% H2O/10% D2O	600 mM	6	1 atm	298	Bruker AVANCE III 600
7	3D HNCA	1 mM [U-13C; U-15N] myristoylated retroviral matrix protein, 100 mM phosphate, 300 mM sodium choride, 5 mM DTT	90% H2O/10% D2O	600 mM	6	1 atm	298	Bruker AVANCE III 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	600

NMR Refinement
Method	Details	Software
simulated annealing		CcpNmr Analysis

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	100
Conformers Submitted Total Number	30
Representative Model	1 (fewest violations)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin		Bruker Biospin
2	peak picking	CcpNmr Analysis		CCPN
3	structure calculation	Xplor-NIH		Schwieters, Kuszewski, Tjandra and Clore
4	processing	TopSpin		Bruker Biospin

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.